SELLAS Life Sciences Group (FRA:RXK3) 3-Year EBITDA Growth Rate : 13.80% (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is SELLAS Life Sciences Group 3-Year EBITDA Growth Rate?

SELLAS Life Sciences Group's EBITDA per Share for the three months ended in Mar. 2024 was €-0.20.

During the past 3 years, the average EBITDA Per Share Growth Rate was 13.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 51.40% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 66.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of SELLAS Life Sciences Group was 83.10% per year. The lowest was 3.90% per year. And the median was 37.40% per year.

Competitive Comparison of SELLAS Life Sciences Group's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, SELLAS Life Sciences Group's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SELLAS Life Sciences Group's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SELLAS Life Sciences Group's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where SELLAS Life Sciences Group's 3-Year EBITDA Growth Rate falls into.

SELLAS Life Sciences Group 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

SELLAS Life Sciences Group (FRA:RXK3) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

SELLAS Life Sciences Group 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of SELLAS Life Sciences Group's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

SELLAS Life Sciences Group (FRA:RXK3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SELLAS Life Sciences Group Inc (FRA:RXK3) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

SLS:USA

Address

7 Times Square, Suite 2503, New York, NY, USA, 10036

Website

https://www.sellaslifesciences.com

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

SELLAS Life Sciences Group (FRA:RXK3) Headlines

No Headlines